Therefore, CFP may be expected to be an independent risk factor for the prognosis of lung cancer and gastric cancer, and may be involved in the regulation of relevant immune mechanisms in the tumor microenvironment, which need to be further identified in more clinical trials and basic experiments. This evidence concerns the gene CFP and gastric cancer.